Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This observational study is being conducted in patients receiving statin treatment as
secondary prevention of coronary heart disease under the current standard of care in
compliance with European guidelines. The purpose of the study is to evaluate the percentage
of these patients that reach target LDL levels. Additionally this study will measure the
patient's compliance to treatment as assessed by counting the returned tablets. Both
assessments will be made at visits conducted 6-8 weeks after the first visit and 28-32 weeks
after the first visit.